Harvoni recommended for the treatment of chronic hepatitis C

View source ↗

Summary

EMEA recommended Harvoni as a treatment option for chronic hepatitis C, outlining its suitability for patients with chronic HCV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)